Introduction {#section1-1178632918813311}
============

According to the Institute of Medicine, 30% of dollars spent on health care is waste in the American medical system.^[@bibr1-1178632918813311]^ Berwick and Hackbarth^[@bibr2-1178632918813311]^ conducted additional analysis and placed a midpoint estimate of waste at 34% of national health spending. Although Medicaid programs operate with extremely low margins, and prospective savings will not approach 30%, savings are possible. Medicaid in the state of Texas, for example, represents just over 30% of the state budget and covers 4.4 million people. In 2016, Texas spent US \$18 billion on Medicaid; with the Federal Medical Assistance Percentage (FMAP) at 57.13%, the federal government paid US \$20.5 billion, for the total state + federal shares at US \$38.5 billion.^[@bibr3-1178632918813311]^ Even with only a 5% reduction, annual savings could equal well over US \$1 billion, which could be used to improve care and potentially redistribute funding to chronically underfunded areas, such as payments to physicians. In Alaska, where the FMAP is 50%, the total spending on Medicaid (including state and federal contributions) in 2016 was US \$1.42 billion^[@bibr3-1178632918813311]^; Alaska's portion of this payment is \$710 million. Applying a 5% savings would yield US \$35.5 million for other state programs and priorities.

This article adds to current work on Medicaid reform by exploring specific pathways to find and estimate savings that, at the same time, maintain or improve quality of care. These results should be applicable to Medicaid programs across the states, as well as to other parts of the US health care system. We use the "Wedges Model" for examining proposed reductions in health care spending, a framework Berwick and Hackbarth^[@bibr2-1178632918813311]^ refined to examine a variety of cost-saving initiatives to target wasteful spending in key areas such as failures in care coordination/delivery and overtreatment. The key areas identified in the Wedges Model led us to identify 5 approaches to savings, which could contribute to stabilizing health care spending through streamlining and strengthening care coordination and minimizing unnecessary treatment. The innovative initiatives highlighted are adaptable, relatively low-cost investments, yielding meaningful savings to Medicaid. The programs also aid vulnerable and costly health care populations. The proposed initiatives, applied to the 10-state sample to represent the full range of potential cost savings, include reduction in unnecessary care, improved medication adherence in dual-eligible beneficiaries, improved care for dual-eligible beneficiaries to reduce hospital readmissions, reduction in emergency department (ED) visits among children in Medicaid and dual-eligible beneficiaries, and improved coordination for end-of-life care.

Pathways to Savings {#section2-1178632918813311}
===================

Health workforce initiatives {#section3-1178632918813311}
----------------------------

### To reduce overutilization of EDs {#section4-1178632918813311}

The overuse of EDs is a large drain of health care dollars. Routine care provided in an ED setting can be 2 to 5 times more expensive than the same care provided in an alternate setting such as an urgent care clinic.^[@bibr4-1178632918813311]^ A Health Partners study discovered charges for treating strep throat in the ED to be US \$328, US \$130 at an urgent care center, and US \$122 in a primary care office.^[@bibr5-1178632918813311]^ Clearly, based on these figures, it is critical to find ways to treat as many patients as possible outside of an ED due to the 261% price premium that ED care costs.

Massachusetts conducted an in-depth analysis of their ED usage and the emergent status of patient's health when visiting the ED. Of all ED visits, 42% were classified as avoidable.^[@bibr6-1178632918813311]^ If we extrapolated this percentage to California, this would translate to 5 749 000 avoidable ED visits per year, and in South Dakota, this percentage would translate to 114 000 annual avoidable ED visits.^[@bibr7-1178632918813311]^ The Massachusetts report also highlighted disparities between incomes: the residents in the lowest income quartile, after adjusting for age and sex, had greater than 3 times the avoidable ED rate than residents in the highest income quartile. The lowest income quartile would represent uninsured and Medicaid populations.

The most beneficial program to reduce ED usage is one that prevents unnecessary trips to the ED. This can involve enhancing programs such as "Grand-Aides" to assist patients in health care management and reduce their perceived need for ED treatment. Grand-Aides are nurse aides who are closely supervised by nurses and foster relationships with patients and family with the goal of appropriate use of the ED. Calculations indicate Grand-Aides could potentially reduce Medicaid ED visits by 74% in Medicaid children and patients dually eligible for Medicaid and Medicare support ("dual eligibles").^[@bibr8-1178632918813311]^

### To improve medication adherence among dual eligibles {#section5-1178632918813311}

About 50% of patients with chronic diseases take their medications appropriately.^[@bibr9-1178632918813311]^ Medication nonadherence among the other 50% generates a significant cost burden. Dual eligibles represent 15% of the national Medicaid population but require 33% of Medicaid spending.^[@bibr10-1178632918813311]^ This high level of spending can be partially attributed to the dual-eligible population's vulnerability and complicated chronic health conditions. Significantly, the Grand-Aides program has achieved a 91% medication adherence in patients with heart failure 1 month after discharge.^[@bibr11-1178632918813311]^

### To reduce avoidable hospitalization among dual eligibles {#section6-1178632918813311}

Dual-eligible beneficiaries are at a higher risk for potentially avoidable hospitalizations---admissions and readmissions. Among hospital visits in this population, just over one quarter (26%) of hospitalizations have been determined to be unnecessary, many due to readmissions.^[@bibr12-1178632918813311]^ The Grand-Aides program is one initiative achieving the aim of reducing readmissions with a demonstrated ability to reduce hospital readmissions by 58%.^[@bibr11-1178632918813311]^

Payment Initiatives {#section7-1178632918813311}
===================

To reduce unnecessary care {#section8-1178632918813311}
--------------------------

Most physicians are still predominately paid on a fee-for-service (FFS) basis. Medicaid programs could propose new payment methods. For physicians who are already part of hospital systems or Accountable Care Organizations (ACOs) it would be reasonable to convert to a salaried system (at their current yearly income), with a relatively modest bonus (ie, 5%-10%) for quality. Physician income does not need to decrease with these changes. As Medicaid generates savings in this and other areas, physician payment should increase to attract more physicians into caring for Medicaid patients. Salary + bonus would be the dominant method of payment. For physicians not in systems, Medicaid could test the resultant effect on patient care of paying a certain amount per patient with a bonus for quality. It could also change to FFS payment with not only incentives for quality but also disincentives for doing what physicians' own specialty societies determine in their guidelines to be unnecessary or harmful. The Centers for Medicare and Medicaid Services (CMS) has announced that by the end of 2018, more than half of Medicare dollars will be paid via alternative payment models that focus on reducing the negative incentives associated with paying physicians based on FFS. Of note, the health care systems in the United States that are routinely ranked the highest for quality (eg, Mayo Clinic, Cleveland Clinic, and Kaiser Permanente) have salaried physicians, some with and some without a bonus. Such systems have demonstrated savings between 20% and 46% due to a decrease in tests ordered and procedures performed.^[@bibr13-1178632918813311],[@bibr14-1178632918813311]^ For the purposes of this analysis, we assume 15% savings.

Advance directives {#section9-1178632918813311}
------------------

### To improve end-of-life care {#section10-1178632918813311}

Approximately US \$205 billion is spent in the United States on patients in the last year of life or 13% of the annual total spending on health care.^[@bibr15-1178632918813311]^ A number of strategies are incorporated to improve the quality of a person's last days. These approaches must be exquisitely sensitive to improving the quality of life of the patient and loved ones address the mislabeled "death panels" from the past. The most successful approach involves recording the wishes of the individual patient and family, broadly called "advance directives," which fall into 3 categories: living wills, power of attorney and health care proxy. One calculation places the savings through advance directives at US \$5585 per patient.^[@bibr16-1178632918813311]^ This figure was the most recent study reported from a 2016 systematic review of advanced care planning cost savings. Estimates in the review varied widely from US \$1041 to US \$64 830 per patient, based on the length of the study and the method for measuring cost.^[@bibr17-1178632918813311]^

These savings are realized by reduced usage of EDs and reductions of extraordinary life-saving measures while honoring the patient's and their family's wishes. Only 65% of nursing home patients have an advance directive.^[@bibr18-1178632918813311]^ There is a great opportunity, as up to 90% of nursing home patients and families will complete advanced directives if a physician initiates the discussion.^[@bibr19-1178632918813311]^ The percentage of patients aged 65 and older with recorded advance care plans or surrogate decision makers designated in their medical records is a quality communication and care coordination process measure in the Merit-Based Incentive Payment System for many disciplines.

Methods {#section11-1178632918813311}
=======

Using Urban Institute calculations as of January 2017, based on CMS Form 64, the 5 lowest total Medicaid expenditure states (Wyoming, South Dakota, Montana, Vermont, and Alaska) and the 5 highest Medicaid expenditure states (Florida, Pennsylvania, Texas, New York, and California), were selected for evaluation. Note that North Dakota and Idaho were likely among the lowest Medicaid expenditure states, but they did not have complete reporting to generate adequate data for equal comparisons; therefore, these states were not used in this analysis. Enrollment figures for Medicaid, full dual-eligible beneficiaries, and children enrolled in Medicaid were obtained from the December 2016 MACPAC Databook for various calculations.^[@bibr20-1178632918813311]^ The FY17 FMAP was applied to reflect the state share of Medicaid savings. Each approach to savings was applied to the 10-state sample to evaluate potential cost savings. If all programs are implemented, the total financial benefit to states ranges from US \$11.8 million in Wyoming to US \$1.7 billion in California ([Table 1](#table1-1178632918813311){ref-type="table"}).

###### 

Overall proposed cost savings.

![](10.1177_1178632918813311-table1)

                                                               5 states with lowest Medicaid expenditures   5 states with highest Medicaid expenditures                                                                                                        
  ------------------------------------------------------------ -------------------------------------------- --------------------------------------------- ------------ ------------ ------------ --------------- ------------- --------------- --------------- ---------------
  Salaried physicians for reduction in unnecessary care        6 858 000                                    10 043 000                                    14 245 000   373 000      24 337 000   69 995 000      12 053 000    67 414 000      95 008 000      166 213 000
  Dual-eligible medication adherence program                   10 499 000                                   20 998 000                                    25 498 000   43 492 000   22 498 000   602 945 000     577 447 000   673 438 000     1 133 896 000   2 078 809 000
  End-of-life coordination of care                             2 052 000                                    4 105 000                                     4 985 000    8 500 000    4 398 000    117 871 000     112 887 000   131 652 000     221 669 000     406 393 000
  Reduction in avoidable dual-eligible hospital readmissions   3 453 000                                    6 914 000                                     8 397 000    14 313 000   7 406 000    198 485 000     190 094 000   221 689 000     373 275 000     684 338 000 
  Emergency department visit reduction                         818 000                                      1 273 000                                     1 380 000    1 587 000    1 270 000    35 378 000      23 154 000    49 099 000      45 760 000      84 075 000
  Total cost savings to Medicaid                               23 680 000                                   43 333 000                                    54 505 000   68 265 000   59 909 000   1 024 674 000   915 635 000   1 143 292 000   1 869 608 000   3 419 828 000

Abbreviations: AK, Alaska; CA, California; FL, Florida; MT, Montana; NY, New York; PA, Pennsylvania; SD, South Dakota; TX, Texas; VT, Vermont; WY, Wyoming.

Results {#section12-1178632918813311}
=======

This research explored the states from both ends of the spending spectrum: the 5 with the lowest annual Medicaid expenditures---Wyoming, South Dakota, Montana, Vermont, and Alaska---and those with the highest---California, New York, Texas, Pennsylvania, and Florida. This spectrum demonstrates the range of potential cost-saving measures, from US \$23.6 million in Wyoming to US \$3.4 billion in California.

Reduction in Overutilization of EDs {#section13-1178632918813311}
===================================

Using a statistic of 24.8% of Medicaid children^[@bibr21-1178632918813311]^ and 44% of dual-eligible beneficiaries,^[@bibr22-1178632918813311]^ ED visits are calculated for each state for these populations. Next, 50% of the maximum possible reduction from the Grand-Aides program is applied, which is a 37% reduction. The savings applied include the cost of the Grand-Aides program. If the Grand-Aides program were implemented to assist these key populations (assuming 50% of the possible benefit = 37% reduction), it could result in Medicaid savings of US \$243 million in this 10-state sample, with state savings ranging from US \$409 000 in Wyoming to US \$42 million in California ([Table 2](#table2-1178632918813311){ref-type="table"}).

###### 

Savings calculations for reduction in emergency department use for children and dual eligibles in Medicaid.

![](10.1177_1178632918813311-table2)

                                                                                5 states with lowest Medicaid expenditures   5 states with highest Medicaid expenditures                                                                                           
  ----------------------------------------------------------------------------- -------------------------------------------- --------------------------------------------- ----------- ----------- ----------- ------------ ------------ ------------ ------------ ------------
  Total Medicaid Pop (FY13, average monthly enrollment), n                      68 000                                       107 000                                       114 000     170 000     111 000     3 386 000    2 159 000    4 081 000    5 115 000    9 307 000
  Children as % of Medicaid population                                          65                                           59                                            57          34          55          51           42           63           35           36
  Children on Medicaid, n                                                       44 000                                       63 000                                        65 000      58 000      61 000      1 727 000    914 000      2 590 000    1 815 000    3 340 000
  Average ED use for Medicaid children 24.8%, n                                 10 912                                       15 624                                        16 120      14 384      15 128      428 296      226 672      642 320      450 120      828 320
  Grand-Aides reduces ED visits by 37% (assume 50% of opportunity of 74%), n    4037                                         5780                                          5964        5322        5597        158 469      83 868       237 658      166 544      306 478
  Grand-Aides US \$158 savings per ED visit, including cost of program, US \$   637 846                                      913 240                                       942 312     840 876     884 326     25 038 102   13 251 144   37 549 964   26 313 952   48 423 524
  Dual-eligible population, n                                                   7000                                         14 000                                        17 000      29 000      15 000      402 000      385 000      449 000      756 000      1 386 000
  Average ED usage for dual-eligible population 44%, n                          3080                                         6160                                          7480        12 760      6600        176 880      169 400      197 560      332 640      609 840
  Grand-Aides reduces ED visits by 37% (assume 50% of opportunity of 74%), n    1139                                         2279                                          2767        4721        2442        65 445       62 678       73 097       123 076      225 640
  Grand-Aides US \$158 savings per ED visit, US \$                              180 057                                      360 113                                       437 280     745 918     385 836     10 340 310   9 903 124    11 549 357   19 446 134   35 651 246
  Total Medicaid savings through reduction in ED visits, US \$                  817 903                                      1 273 353                                     1 379 592   1 586 794   1 270 162   35 378 412   23 154 268   49 099 321   45 760 086   84 074 770
  State share, %                                                                50                                           45                                            34          45.54       50          38.9         48           43.82        50           50
  State savings, US \$                                                          408 951                                      573 772                                       475 131     722 625     635 081     13 762 202   11 164 988   21 515 322   22 880 043   42 037 385

Abbreviations: AK, Alaska; CA, California; FL, Florida; MT, Montana; NY, New York; PA, Pennsylvania; SD, South Dakota; TX, Texas; VT, Vermont; WY, Wyoming.

Data obtained from Garson et al^[@bibr8-1178632918813311]^; MACPAC^[@bibr20-1178632918813311]^; Cubanski et al^[@bibr22-1178632918813311]^; and Gindi and Jones.^[@bibr21-1178632918813311]^

Improved Medication Adherence {#section14-1178632918813311}
=============================

Improved adherence was calculated from 50% to 75% for 4 chronic conditions: hypertension, diabetes, heart failure, and dyslipidemia.^[@bibr23-1178632918813311]^ State populations for each chronic condition were estimated using data from the CMS Chronic Conditions Chartbook.^[@bibr24-1178632918813311]^ Assuming that 50% of patients take their medication appropriately, an improvement to 75% adherence would produce savings displayed in [Table 3](#table3-1178632918813311){ref-type="table"}. These significant savings also incorporate increased drug cost as a result of drug adherence. Importantly, those expenses are offset due to overall reductions in health care expenditures for costly services such as ED visits, hospital admissions, additional diagnostic testing, and increased pharmacy expenses related to treatment. For patients with hypertension, potential savings in the 10-state sample equal US \$2 billion; for heart failure, total savings equal US \$1.55 billion; for diabetes, US \$1.17 billion; and for dyslipidemia, US \$260 million. The potential cost savings for state Medicaid range from US \$5.2 million in Wyoming to US \$1 billion in California.

###### 

Savings calculations for improvement in drug adherence by dual eligibles, by disease category.

![](10.1177_1178632918813311-table3)

                                                                5 states with lowest Medicaid expenditures   5 states with highest Medicaid expenditures                                                                                                    
  ------------------------------------------------------------- -------------------------------------------- --------------------------------------------- ------------ ------------ ------------ ------------- ------------- ------------- --------------- ---------------
  Total dual-eligible population                                7000                                         14 000                                        17 000       29 000       15 000       402 000       385 000       449 000       756 000         1 386 000
  Hypertension                                                                                                                                                                                                                                              
   60% of pop, n                                                4200                                         8400                                          10 200       17 400       9000         241 200       231 000       269 400       453 600         831 600
   50% nonadherence, n                                          2100                                         4200                                          5100         8700         4500         120 600       115 500       134 700       226 800         415 800
   Savings with 75% adherence at US \$3908/patient, US \$       4 103 400                                    8 206 800                                     9 965 400    16 999 800   8 793 000    235 652 400   225 687 000   263 203 800   443 167 200     812 473 200
  Heart failure                                                                                                                                                                                                                                             
   23% of pop, n                                                1610                                         3220                                          3910         6670         3450         92 460        88 550        103 270       173 880         318 780
   50% nonadherence, n                                          805                                          1610                                          1955         3335         1725         46 230        44 275        51 635        86 940          159 390
   Savings with 75% adherence at US \$7823 per patient, US \$   3 148 757                                    6 297 515                                     7 646 982    13 040 941   6 747 337    180 828 645   173 181 662   201 970 302   340 065 810     623 453 985
  Diabetes                                                                                                                                                                                                                                                  
   36% of pop, n                                                2520                                         5040                                          6120         10 440       5400         144 720       138 600       161 640       272 160         498 960
   50% nonadherence, n                                          1260                                         2520                                          3060         5220         2700         72 360        69 300        80 820        136 080         249 480
   Savings with 75% adherence at US \$3756 per patient, US \$   2 366 280                                    4 732 560                                     5 746 680    9 803 160    5 070 600    135 892 080   130 145 400   151 779 960   255 558 240     468 523 440
  Dyslipidemia                                                                                                                                                                                                                                              
   40% of pop, n                                                2800                                         5600                                          6800         11 600       6000         160 800       154 000       179 600       302 400         554 400
   50% nonadherence, n                                          1400                                         2800                                          3400         5800         3000         80 400        77 000        89 800        151 200         277 200
   Savings with 75% adherence at US \$1258 per patient, US \$   800 600                                      1 761 200                                     2 138 600    3 648 200    1 887 000    50 571 600    48 433 000    56 484 200    95 104 800      174 358 800
  Total savings                                                 10 499 037                                   20 998 075                                    25 497 662   43 492 101   22 497 937   602 944 725   577 447 062   673 438 262   1 133 896 050   2 078 809 425
   State share, %                                               50                                           45.06                                         34.44        45.54        50           38.9          48.22         43.82         50              50
   State savings---FMAP 2017 contributions applied, US \$       5 249 519                                    9 461 733                                     8 781 395    19 806 302   11 248 969   234 545 498   278 444 973   295 100 646   566 948 025     1 039 404 712

Abbreviations: AK, Alaska; CA, California; FL, Florida; MT, Montana; NY, New York; PA, Pennsylvania; SD, South Dakota; TX, Texas; VT, Vermont; WY, Wyoming.

Data drawn from Roebuck et al^[@bibr23-1178632918813311]^ and Centers for Medicare and Medicaid Services.^[@bibr24-1178632918813311]^

Reduction in Avoidable Hospitalizations {#section15-1178632918813311}
=======================================

Assuming the Grand-Aides program would achieve 50% reduction in hospital admissions, and calculating the cost of a readmission based on US \$15,435,^[@bibr25-1178632918813311]^ the net savings to the Medicaid program could range from US \$3.4 million in Wyoming to US \$684 million in California, including the expense of operating the Grand-Aides program ([Table 4](#table4-1178632918813311){ref-type="table"}).^[@bibr26-1178632918813311]^\]

###### 

Savings calculations for reduction in hospital readmission costs for dual eligibles.

![](10.1177_1178632918813311-table4)

                                                                                                             5 states with lowest Medicaid expenditures   5 states with highest Medicaid expenditures                                                                                                  
  ---------------------------------------------------------------------------------------------------------- -------------------------------------------- --------------------------------------------- ------------ ------------ ------------ ------------- ------------- ------------- ------------- ---------------
  Full dual-eligible population, n                                                                           7000                                         14 000                                        17 000       29 000       15 000       402 000       385 000       449 000       756 000       1 386 000
  Dual-eligible hospitalization (27%), n                                                                     1890                                         3780                                          4590         7830         4050         108 540       103 950       121 230       204 120       374 220
  Avoidable hospitalizations (26%), n                                                                        491                                          983                                           1193         2035         1053         28 220        27 027        31 519        53 071        97 297
  Expense to Medicaid calculated at US \$15 667 per readmission, US \$                                       7 692 497                                    15 400 661                                    18 702 661   31 882 345   16 497 351   442 122 740   423 432 009   493 808 173   831 463 357   1 524 352 099
  Grand-Aides could reduce readmissions by 50%, US \$                                                        3 846 248                                    7 700 330                                     9 351 330    15 941 172   8 248 675    221 061 370   211 716 004   246 904 086   415 731 678   762 176 049
  Grand-Aides cost US \$800 per individual per year, applied to 26% preventable hospital population, US \$   392 800                                      786 400                                       954 400      1 628 000    842 400      22 576 000    21 621 600    25 215 200    42 456 800    77 837 600
  Calculated Medicaid savings, US \$                                                                         3 453 448                                    6 913 930                                     8 396 930    14 313 172   7 406 275    198 485 370   190 094 404   221 688 886   373 274 878   684 338 449
  State share, %                                                                                             50                                           45.06                                         34.44        45.54        50           38.9          48.22         43.82         50            50
  State savings, US \$                                                                                       1 726 724                                    3 116 799                                     2 891 902    6 518 218    3 703 137    77 210 808    91 663 521    97 144 069    186 637 439   342 169 224

Abbreviations: AK, Alaska; CA, California; FL, Florida; MT, Montana; NY, New York; PA, Pennsylvania; SD, South Dakota; TX, Texas; VT, Vermont; WY, Wyoming.

Data drawn from Segal^[@bibr12-1178632918813311]^; Garson^[@bibr26-1178632918813311]^; and Fitch et al.^[@bibr25-1178632918813311]^

Reduction in Unnecessary Procedures {#section16-1178632918813311}
===================================

Assuming that paying physicians a salary plus bonus could result in a 15% reduction in tests and procedures; in the 10-state sample (based on the 2016 Medicaid expenditure data),^[@bibr27-1178632918813311]^ these measures result in state savings ranging from US \$3.4 million in Wyoming to US \$83.1 million in California ([Table 5](#table5-1178632918813311){ref-type="table"}). Vermont classifies most of the Medicaid expenditures as "other services" so the state savings for this innovation are small, US \$170 000.

###### 

Savings calculations for reduction in unnecessary care with salaried physicians.

![](10.1177_1178632918813311-table5)

                                              5 states with lowest Medicaid expenditures   5 states with highest Medicaid expenditures                                                                                                 
  ------------------------------------------- -------------------------------------------- --------------------------------------------- ------------ ----------- ------------- ------------- ------------ ------------- ------------- ---------------
  Medicaid physician, lab, and X-ray, US \$   45 722 882                                   66 956 387                                    94 969 409   2 488 213   162 246 654   466 630 080   80 351 103   449 423 819   633 387 993   1 108 088 171
  15% savings                                 6 858 432                                    10 043 458                                    14 245 411   373 232     24 336 998    69 994 512    12 052 665   67 413 572    95 008 198    166 213 225
  State share, %                              50                                           45.06                                         34.44        45.54       50            38.9          48.22        43.82         50            50
  State savings, US \$                        3 429 216                                    4 525 582                                     4 906 119    170 011     12 168 499    27 227 865    5 811 795    29 540 627    47 504 099    83 106 612

Abbreviations: AK, Alaska; CA, California; FL, Florida; MT, Montana; NY, New York; PA, Pennsylvania; SD, South Dakota; TX, Texas; VT, Vermont; WY, Wyoming.

Data obtained from KFF as of January 2017, The structure of Vermont's Medicaid program formulates most of the state's Medicaid expenditures in the category of "Other Services."

Improved End-of-Life Care {#section17-1178632918813311}
=========================

About 21% of dual-eligible beneficiaries are in long-term services and supportive living according to the 2017 MedPAC Databook.^[@bibr10-1178632918813311]^ End-of-life care cost savings were estimated for each state by applying a 25% increase in advance directives among this population with the estimated saving of US \$5585 per directive. This results in state savings ranging from US \$1 million in Wyoming to US \$203 million in California ([Table 6](#table6-1178632918813311){ref-type="table"}).

###### 

Savings calculations for coordination of end-of-life care.

![](10.1177_1178632918813311-table6)

                                                                            5 states with lowest Medicaid expenditures   5 states with highest Medicaid expenditures                                                                                               
  ------------------------------------------------------------------------- -------------------------------------------- --------------------------------------------- ----------- ----------- ----------- ------------- ------------- ------------- ------------- -------------
  Full dual-eligible population, n                                          7000                                         14 000                                        17 000      29 000      15 000      402 000       385 000       449 000       756 000       1 386 000
  21% in long-term services and support, n                                  1470                                         2940                                          3570        6090        3150        84 420        80 850        94 290        158 760       291 060
  With 25% increase in advance directives at US \$5585 per patient, US \$   2 052 487                                    4 104 975                                     4 984 612   8 500 370   4 398 187   117 871 425   112 886 812   131 652 412   221 668 650   406 392 525
  State share, %                                                            50                                           45.06                                         34.44       45.54       50          38.9          48.22         43.82         50            50
  State savings, US \$                                                      1 026 243                                    1 849 701                                     1 714 706   3 871 068   2 199 093   45 851 984    54 434 020    57 690 086    110 834 325   203 196 262

Abbreviations: AK, Alaska; CA, California; FL, Florida; ID, Idaho; MT, Montana; NY, New York; PA, Pennsylvania; SD, South Dakota; TX, Texas; VT, Vermont; WY, Wyoming.

Data obtained from Nicholas et al^[@bibr16-1178632918813311]^ and The Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission.^[@bibr10-1178632918813311]^

Discussion and Conclusions {#section18-1178632918813311}
==========================

Several caveats are important related to the estimated improved adherence calculations: first, the savings are in the short term (ie, hospital admissions over several years) and do not take into account the cost of future disease if the current disease is well-controlled (eg, hypertension is well-controlled and a stroke is avoided, only to have the patient get cancer). Second, there is clear overlap in the patient diagnoses (ie, many patients with diabetes have heart disease). Improvement (and medication adherence) in one of these diagnoses will likely have a positive effect on the other diseases in the patient and therefore these are, again, maximal numbers. Personal reinforcement and teaching are among the most promising approaches to improving medication adherence, as the American Diabetes Association recognizes and recommends.^[@bibr28-1178632918813311]^ Programs such as Grand-Aides with a 91% medication adherence could be extremely beneficial.

Physician Payments {#section19-1178632918813311}
==================

Although combining alternative physician payment models are the basis for part of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), it is unwieldy. In addition, there will be added expenses as managed care companies and physicians switch to a value-based payment system because the data infrastructure to track these metrics must be in place. These expenses must be netted against potential savings (ie, paid to systems and physicians) as the requirements for financial outlays are real. This issue should be addressed through more sophisticated and interoperable Electronic Health Record (EHR) systems, which are, unfortunately, likely a decade away.

An alternative method to reduce unnecessary care would be to examine the 20 most expensive procedures and tests (because of high volume, high price, or both) and compare the indications for the tests or procedures reported by the ordering physician to national guidelines produced by the physician's specialty society. A recent such analysis revealed that 34% of echocardiograms performed on preoperative patients were unnecessary and were outside the recommended practice guidelines.^[@bibr29-1178632918813311]^ We are recommending the physician payment change because it could be achieved more simply (eg, the MACRA regulations could provide an incentive for programs in which at least 50% of their physicians are salaried).

These estimates do not take into account existing state programs that could have already achieved some of the savings. The program overlap poses a significant limitation (ie, the same savings may be attributed to more than one program), as well. The data are likely to be correct within an order of magnitude; rather than focusing on the exact amounts, we suggest that "large (say, 10%), medium (5%) and small (2.5%)" be attached to the possible program savings and be made available as a potential supplement to the cost-saving work already being done by the state Medicaid programs.

We have examined a number of possible approaches to reducing the expense of Medicaid. These savings should remain in the Medicaid program and, for example, help to cover more people and increase physician reimbursement. Increased reimbursements will enhance the number of physicians seeing Medicaid patients, thus improving access for the underserved. If all programs are implemented, the total financial benefit to states ranges from US \$11.8 million in Wyoming to US \$1.7 billion in California, as illustrated in [Table 1](#table1-1178632918813311){ref-type="table"}. These 5 initiatives also could be applied to commercially insured patients or those covered by Medicare, resulting in major savings across the United States. Realizing these savings in achievable ways suggested in this article could make a major dent in the rising cost of health care.
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